Effects of 2 Exercise Training Programs on Physical Activity in Daily Life in Patients With COPD

References

1. 1.↵
   1. Lacasse Y,
   2. Brosseau L,
   3. Milne S,
   4. Martin S,
   5. Wong E,
   6. Guyatt GH,
   7. et al

   . Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;(3):CD003793.
2. 2.↵
   1. Troosters T,
   2. Casaburi R,
   3. Gosselink R,
   4. Decramer M

   . Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172(1):19–38.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Pitta F,
   2. Troosters T,
   3. Probst VS,
   4. Langer D,
   5. Decramer M,
   6. Gosselink R

   . Are patients with COPD more active after pulmonary rehabilitation? Chest 2008;134(2):273–280.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Nici L,
   2. Donner C,
   3. Wouters E,
   4. ZuWallack R,
   5. Ambrosino N,
   6. Bourbeau J,
   7. et al

   . American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173(12):1390–1413.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Clark CJ,
   2. Cochrane L,
   3. Mackay E

   . Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur Respir J 1996;9(12):2590–2596.

   OpenUrlAbstract
6. 6.↵
   1. Normandin EA,
   2. McCusker C,
   3. Connors M,
   4. Vale F,
   5. Gerardi D,
   6. ZuWallack RL

   . An evaluation of two approaches to exercise conditioning in pulmonary rehabilitation. Chest 2002;121(4):1085–1091.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Dourado VZ,
   2. Tanni SE,
   3. Antunes LC,
   4. Paiva SA,
   5. Campana AO,
   6. Renno AC,
   7. et al

   . Effect of three exercise programs on patients with chronic obstructive pulmonary disease. Braz J Med Biol Res 2009;42(3):263–271.

   OpenUrlPubMed
8. 8.↵
   1. Pitta F,
   2. Troosters T,
   3. Spruit MA,
   4. Decramer M,
   5. Gosselink R

   . Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005;86(10):1979–1985.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Langer D,
   2. Gosselink R,
   3. Sena R,
   4. Burtin C,
   5. Decramer M,
   6. Troosters T

   . Validation of two activity monitors in patients with COPD. Thorax 2009;64(7):641–642.

   OpenUrlFREE Full Text
10. 10.↵
    1. Pitta F,
    2. Troosters T,
    3. Spruit MA,
    4. Probst VS,
    5. Decramer M,
    6. Gosselink R

    . Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972–977.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Pereira CAC,
    2. Barreto SP,
    3. Simões JG,
    4. Pereira FWL,
    5. Gerstler JG,
    6. Nakatani J

    . Valores de referência para espirometria em uma amostra da população brasileira adulta. J Bras Pneumol 1992;18:10–22. Article in Portuguese.

    OpenUrl
13. 13.↵
    1. Brooks D,
    2. Solway S,
    3. Gibbons WJ

    . ATS statement on six-minute walk test. Am J Respir Crit Care Med 2003;167(9):1287.

    OpenUrlPubMedWeb of Science
14. 14.↵
    1. Troosters T,
    2. Gosselink R,
    3. Decramer M

    . Six minute walking distance in healthy elderly subjects. Eur Respir J 1999;14(2):270–274.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167(2):211–277.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Probst VS,
    2. Troosters T,
    3. Pitta F,
    4. Decramer M,
    5. Gosselink R

    . Cardiopulmonary stress during exercise training in patients with COPD. Eur Respir J 2006;27(6):1110–1118.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Lukaski HC

    . Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 1987;46(4):537–556.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Kyle UG,
    2. Pichard C,
    3. Rochat T,
    4. Slosman DO,
    5. Fitting JW,
    6. Thiebaud D

    . New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dual-energy X-ray absorptiometry. Eur Respir J 1998;12(4):960–966.

    OpenUrlAbstract
19. 19.↵
    1. Black LF,
    2. Hyatt RE

    . Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99(5):696–702.

    OpenUrlPubMedWeb of Science
20. 20.↵
    1. Neder JA,
    2. Andreoni S,
    3. Lerario MC,
    4. Nery LE

    . Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res 1999;32(6):719–727.

    OpenUrlPubMedWeb of Science
21. 21.↵
    1. Pitta F,
    2. Probst VS,
    3. Kovelis D,
    4. Segretti NO,
    5. Mt LA,
    6. Garrod R,
    7. et al

    . [Validation of the Portuguese version of the London Chest Activity of Daily Living Scale (LCADL) in chronic obstructive pulmonary disease patients]. Rev Port Pneumol 2008;14(1):27–47. Article in Portuguese.

    OpenUrlPubMed
22. 22.↵
    1. Kovelis D,
    2. Segretti NO,
    3. Probst VS,
    4. Lareau SC,
    5. Brunetto AF,
    6. Pitta F

    . Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 2008;34(12):1008–1018.

    OpenUrlPubMed
23. 23.↵
    1. Lareau SC,
    2. Meek PM,
    3. Roos PJ

    . Development and testing of the modified version of the pulmonary functional status and dyspnea questionnaire (PFSDQ-M). Heart Lung 1998;27(3):159–168.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Bestall JC,
    2. Paul EA,
    3. Garrod R,
    4. Garnham R,
    5. Jones PW,
    6. Wedzicha JA

    . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54(7):581–586.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Camelier A,
    2. Rosa FW,
    3. Salim C,
    4. Nascimento OA,
    5. Cardoso F,
    6. Jardim JR

    . Using the Saint George's Respiratory Questionnaire to evaluate quality of life in patients with chronic obstructive pulmonary disease: validating a new version for use in Brazil. J Bras Pneumol 2006;32(2):114–122.

    OpenUrlPubMed
26. 26.↵
    1. Jones PW,
    2. Quirk FH,
    3. Baveystock CM,
    4. Littlejohns P

    . A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321–1327.

    OpenUrlCrossRefPubMedWeb of Science
27. 27.↵
    1. Paulin E,
    2. Brunetto AF,
    3. Carvalho CRF

    . Efeitos de programa de exercícios físicos direcionado ao aumento da mobilidade torácica em pacientes portadores de doença pulmonar obstrutiva crônica. J Bras Pneumol 2003;29(5):287–294. Article in Portuguese.

    OpenUrl
28. 28.↵
    1. Troosters T,
    2. Gosselink R,
    3. Decramer M

    . Short and long term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000;109(3):207–212.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Horowitz MB,
    2. Littenberg B,
    3. Mahler DA

    . Dyspnea ratings for prescribing exercise intensity in patients with COPD. Chest 1996;109(5):1169–1175.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Spruit MA,
    2. Gosselink R,
    3. Troosters T,
    4. De Paepe K,
    5. Decramer M

    . Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 2002;19(6):1072–1078.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Walker PP,
    2. Burnett A,
    3. Flavahan PW,
    4. Calverley PM

    . Lower limb activity and its determinants in COPD. Thorax 2008;63(8):683–689.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Vagaggini B,
    2. Costa F,
    3. Antonelli S,
    4. De SC,
    5. De CG,
    6. Martino F,
    7. et al

    . Clinical predictors of the efficacy of a pulmonary rehabilitation programme in patients with COPD. Respir Med 2009;103(8):1224–1230.

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. Odemberg N,
    2. Colange AL,
    3. Barzon D,
    4. Nascimento CHS,
    5. Probst VS,
    6. Brunetto AF,
    7. et al

    . Responsiveness of 3 subjective instruments for assessment of functional status in patients with COPD (abstract). Eur Respir J 2008;32(Suppl):729S.

    OpenUrl
34. 34.↵
    1. Fischer MJ,
    2. Scharloo M,
    3. Abbink JJ,
    4. van 't Hul AJ,
    5. van Ranst D,
    6. Rudolphus A,
    7. et al

    . Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med 2009;103(10):1564–1571.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Bourbeau J,
    2. Julien M,
    3. Maltais F,
    4. Rouleau M,
    5. Beaupre A,
    6. Begin R,
    7. et al

    . Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163(5):585–591.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Cote CG,
    2. Celli BR

    . Pulmonary rehabilitation and the BODE index in COPD. Eur Respir J 2005;26(4):630–636.

    OpenUrlAbstract/FREE Full Text